Review Article on Antioxidants and Ionizing Radiation in Medical Imaging
Importance of Medical Imaging
A recent review article investigates the role of antioxidants in mitigating the adverse effects of ionizing radiation during medical imaging. Medical imaging is essential in assessing various body systems, which is crucial for optimizing treatment plans. Common techniques, such as X-rays and computed tomography (CT), expose patients to ionizing radiation.
Health Risks Associated with Ionizing Radiation
The implications of radiation exposure are significant, as it can lead to DNA damage and elevate cancer risk. Research indicates that approximately 2% of cancers are associated with radiation exposure from CT scans. Consequently, scientists are exploring methods to minimize radiation doses, including the use of radioprotective agents.
Potential of Antioxidants as Radioprotective Agents
Researchers are investigating how antioxidants might reduce DNA damage and subsequently lower the risk of cancer. A team from the United States published a review in the Journal of Translational Medicine focusing on radioprotective agents aimed at preventing cellular damage from ionizing radiation.
Current Use of Radioprotective Agents
While substantial evidence supports the effectiveness of radioprotective agents in alleviating side effects from radiation therapy, these agents are not routinely utilized during diagnostic medical imaging. The review emphasizes that compounds like antioxidants can enhance DNA repair, reduce post-radiation inflammation, and eliminate highly reactive molecules within cells.
Research Findings
Numerous studies involving cell-based and animal models indicate that various antioxidant agents can produce beneficial effects. Notably, a recent human study revealed that multi-agent antioxidant pills could prevent DNA damage in patients undergoing medical scans. However, this study had a limited sample size, necessitating further research to confirm the efficacy of antioxidants prior to medical imaging.
Need for Long-Term Studies
Additionally, there is a lack of long-term studies exploring the role of antioxidants in preventing chronic side effects. Results from extended research would provide a stronger foundation for the use of radioprotective agents to mitigate the negative impacts of diagnostic imaging.
Conclusion and Future Directions
Despite the need for further investigation, the review article summarizes preclinical and clinical data that suggest potential clinical benefits for patients taking radioprotective agents before medical imaging.
Written by Branson Chen, BHSc
Reference: Smith TA, Kirkpatrick DR, Smith S, Smith TK, Pearson T, Kailasam A, Herrmann KZ, Schubert J, Agrawal DK. Radioprotective agents to prevent cellular damage due to ionizing radiation. Journal of Translational Medicine. 2017 Nov 9;15(1):232.
The views and opinions expressed in this sponsored post are those of the advertiser and do not reflect those of Medical News Bulletin. Any websites linked from Medical News Bulletin are created by organizations outside of Medical News Bulletin and are the sole responsibility of those organizations. These links are provided solely for your convenience to access additional information. Medical News Bulletin does not endorse the content on any third-party websites and is not responsible for their accuracy. Your use of third-party websites is at your own risk and subject to the terms and conditions of use as outlined by those sites. Medical News Bulletin does not provide specific medical advice, diagnosis, or treatment and disclaims any obligations or liabilities related to this content.